-
Alvarez FJD, He S, Perilla JR, Jang S, Schulten K, Engelman AN, Scheres SHW, Zhang P, 2017: CryoEM structure of MxB reveals a novel oligomerization interface critical for HIV restriction[J]. Sci Adv, 3, e1701264-e1701264. doi: 10.1126/sciadv.1701264
-
Betancor G, Dicks MDJ, Jimenez-Guardeno JM, Ali NH, Apolonia L, Malim MH, 2019: The GTPase domain of MX2 interacts with the HIV-1 capsid, enabling its short isoform to moderate antiviral restriction[J]. Cell Rep, 29, e1923-.
-
Buffone C, Schulte B, Opp S, Diaz-Griffero F, 2015: Contribution of MxB oligomerization to HIV-1 capsid binding and restriction[J]. J Virol, 89, 3285-3294. doi: 10.1128/JVI.03730-14
-
Busnadiego I, Kane M, Rihn SJ, Preugschas HF, Hughes J, Blanco-Melo D, Strouvelle VP, Zang TM, Willett BJ, Boutell C, Bieniasz PD, Wilson SJ, 2014: Host and viral determinants of Mx2 antiretroviral activity[J]. J Virol, 88, 7738-7752. doi: 10.1128/JVI.00214-14
-
Butler SL, Hansen MS, Bushman FD, 2001: A quantitative assay for HIV DNA integration in vivo[J]. Nat Med, 7, 631-634. doi: 10.1038/87979
-
Chen Y, Zhang L, Graf L, Yu B, Liu Y, Kochs G, Zhao Y, Gao S, 2017: Conformational dynamics of dynamin-like MxA revealed by single-molecule FRET[J]. Nat Commun, 8, 15744-. doi: 10.1038/ncomms15744
-
Crameri M, Bauer M, Caduff N, Walker R, Steiner F, Franzoso FD, Gujer C, Boucke K, Kucera T, Zbinden A, Munz C, Fraefel C, Greber UF, Pavlovic J, 2018: MxB is an interferon-induced restriction factor of human herpesviruses[J]. Nat Commun, 9, 1980-. doi: 10.1038/s41467-018-04379-2
-
Di Nunzio F, Fricke T, Miccio A, Valle-Casuso JC, Perez P, Souque P, Rizzi E, Severgnini M, Mavilio F, Charneau P, Diaz-Griffero F, 2013: Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication[J]. Virology, 440, 8-18. doi: 10.1016/j.virol.2013.02.008
-
Dick A, Graf L, Olal D, von der Malsburg A, Gao S, Kochs G, Daumke O, 2015: Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity[J]. J Biol Chem, 290, 12779-12792. doi: 10.1074/jbc.M115.650325
-
Dicks MDJ, Betancor G, Jimenez-Guardeno JM, Pessel-Vivares L, Apolonia L, Goujon C, Malim MH, 2018: Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction[J]. PLoS Pathog, 14, e1007408-. doi: 10.1371/journal.ppat.1007408
-
Ebina H, Aoki J, Hatta S, Yoshida T, Koyanagi Y, 2004: Role of Nup98 in nuclear entry of human immunodeficiency virus type 1 cDNA[J]. Microbes Infect, 6, 715-724. doi: 10.1016/j.micinf.2004.04.002
-
Fribourgh JL, Nguyen HC, Matreyek KA, Alvarez FJD, Summers BJ, Dewdney TG, Aiken C, Zhang P, Engelman A, Xiong Y, 2014: Structural insight into HIV-1 restriction by MxB[J]. Cell Host Microbe, 16, 627-638. doi: 10.1016/j.chom.2014.09.021
-
Fricke T, White TE, Schulte B, de Souza Aranha Vieira DA, Dharan A, Campbell EM, Brandariz-Nunez A, Diaz-Griffero F, 2014: MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1[J]. Retrovirology, 11, 68-. doi: 10.1186/s12977-014-0068-x
-
Goujon C, Moncorge O, Bauby H, Doyle T, Ward CC, Schaller T, Hue S, Barclay WS, Schulz R, Malim MH, 2013: Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection[J]. Nature, 502, 559-562. doi: 10.1038/nature12542
-
Goujon C, Greenbury RA, Papaioannou S, Doyle T, Malim MH, 2015: A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2[J]. J Virol, 89, 4676-4680. doi: 10.1128/JVI.00169-15
-
Haller O, Staeheli P, Schwemmle M, Kochs G, 2015: Mx GTPases: dynamin-like antiviral machines of innate immunity[J]. Trends Microbiol, 23, 154-163. doi: 10.1016/j.tim.2014.12.003
-
Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, Schoggins JW, Rice CM, Yamashita M, Hatziioannou T, Bieniasz PD, 2013: MX2 is an interferon-induced inhibitor of HIV-1 infection[J]. Nature, 502, 563-566. doi: 10.1038/nature12653
-
King MC, Raposo G, Lemmon MA, 2004: Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB[J]. Proc Natl Acad Sci USA, 101, 8957-8962. doi: 10.1073/pnas.0403167101
-
Kitagawa Y, Kameoka M, Shoji-Kawata S, Iwabu Y, Mizuta H, Tokunaga K, Fujino M, Natori Y, Yura Y, Ikuta K, 2008: Inhibitory function of adapter-related protein complex 2 alpha 1 subunit in the process of nuclear translocation of human immunodeficiency virus type 1 genome[J]. Virology, 373, 171-180. doi: 10.1016/j.virol.2007.11.033
-
Kong J, Xu B, Wei W, Wang X, Xie W, Yu XF, 2014: Characterization of the amino-terminal domain of Mx2/MxB-dependent interaction with the HIV-1 capsid[J]. Protein Cell, 5, 954-957. doi: 10.1007/s13238-014-0113-5
-
Kong J, Ma M, He S, Qin X, 2016: Mx oligomer: a novel capsid pattern sensor?[J]. Future Microbiol, 11, 1047-1055. doi: 10.2217/fmb-2016-0004
-
Li N, Luo F, Chen Q, Zhu N, Wang H, Xie L, Xiong H, Yue M, Zhang Y, Feng Y, Hou W, 2019: IFN-lambdas inhibit Hantaan virus infection through the JAK-STAT pathway and expression of Mx2 protein[J]. Genes Immun, 20, 234-244. doi: 10.1038/s41435-018-0028-x
-
Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, Liang C, 2013: The interferon-inducible MxB protein inhibits HIV-1 infection[J]. Cell Host Microbe, 14, 398-410. doi: 10.1016/j.chom.2013.08.015
-
Matreyek KA, Wang W, Serrao E, Singh PK, Levin HL, Engelman A, 2014: Host and viral determinants for MxB restriction of HIV-1 infection[J]. Retrovirology, 11, 90-. doi: 10.1186/s12977-014-0090-z
-
Meier K, Jaguva Vasudevan AA, Zhang Z, Bähr A, Kochs G, Häussinger D, Münk C, 2018: Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV)[J]. Virology, 523, 52-63. doi: 10.1016/j.virol.2018.07.024
-
Nigg PE, Pavlovic J, 2015: Oligomerization and GTP-binding requirements of MxA for viral target recognition and antiviral activity against influenza A virus[J]. J Biol Chem, 290, 29893-29906. doi: 10.1074/jbc.M115.681494
-
Schilling M, Bulli L, Weigang S, Graf L, Naumann S, Patzina C, Wagner V, Bauersfeld L, Goujon C, Hengel H, Halenius A, Ruzsics Z, Schaller T, Kochs G, 2018: Human MxB protein is a pan-herpesvirus restriction factor[J]. J Virol, 92, e01056-18.
-
Staeheli P, Haller O, 2018: Human MX2/MxB: a potent interferon-induced postentry inhibitor of herpesviruses and HIV-1[J]. J Virol, 92, e00709-e00718.
-
Verhelst J, Hulpiau P, Saelens X, 2013: Mx proteins: antiviral gatekeepers that restrain the uninvited[J]. Microbiol Mol Biol Rev, 77, 551-566. doi: 10.1128/MMBR.00024-13
-
Wang YX, Niklasch M, Liu T, Wang Y, Shi B, Yuan W, Baumert TF, Yuan Z, Tong S, Nassal M, Wen YM, 2020: Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication[J]. J Hepatol, 75, 865-876.
-
Yi DR, An N, Liu ZL, Xu FW, Raniga K, Li QJ, Zhou R, Wang J, Zhang YX, Zhou JM, Zhang LL, An J, Qin CF, Guo F, Li XY, Liang C, Cen S, 2019: Human MxB inhibits the replication of hepatitis C virus[J]. J Virol, 93, e01285-18.
-
Zhang R, Mehla R, Chauhan A, 2010: Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus -1 preintegration complex (DNA)[J]. PLoS One, 5, e15620-. doi: 10.1371/journal.pone.0015620